Metformin in Older Adults With Type 2 Diabetes (AMEMET)

Study to Evaluate the Drug-drug Interactions Between Metformin and AMG 510 in Healthy Participants

NCT05550129 ·Status: COMPLETED ·Phase: PHASE1

Investigatory Study of Metformin's Pharmacokinetics, Pharmacodynamics and Drug Drug Interactions Classifying the Group by MATE1 Genotype in Healthy Volunteers

NCT01274130 ·Status: COMPLETED ·Phase: NA

Study on DMMET-01 Versus Metformin on Improvement of Metabolic Control in Naive Type 2 Diabetes Patients

NCT00940472 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

The Effects of Metformin on Blood Vessel Structure and Function

NCT00105066 ·Status: COMPLETED ·Phase: PHASE2

Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.

NCT04317703 ·Status: COMPLETED ·Phase: PHASE1

Drug Concentration of Metformin According to Sampling Method

NCT03970434 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single Tablets

NCT01581931 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus

NCT00463502 ·Status: COMPLETED ·Phase: PHASE4

Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients

NCT06495281 ·Status: COMPLETED

BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone

NCT03355014 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Evaluation of Metformin in Relation to the Polymorphism A270S in Healthy Caucasian Volunteers

NCT01237522 ·Status: COMPLETED ·Phase: PHASE4

Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.

NCT04050098 ·Status: UNKNOWN ·Phase: PHASE1

Feasibility Study of Metformin Therapy in ADPKD

NCT02903511 ·Status: COMPLETED ·Phase: PHASE2

ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose Combination

NCT01204580 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes

NCT02548741 ·Status: UNKNOWN ·Phase: NA

Effect of DMMET-01 on Insulin Sensitivity in Naive Type 2 Diabetes Patients (CLAMP)

NCT00940797 ·Status: COMPLETED ·Phase: PHASE2

Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus

NCT05281029 ·Status: UNKNOWN

A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets

NCT01055691 ·Status: COMPLETED ·Phase: PHASE1

Metformin in Non-Alcoholic Fatty Liver Disease

NCT00303537 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered Together

NCT01811953 ·Status: COMPLETED ·Phase: PHASE1

Metformin Pharmacokinetics in Patients With Chronic and Acute Heart Failure

NCT02797340 ·Status: UNKNOWN ·Phase: PHASE4

Initiation and Titration of Amaryl

NCT01144728 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Metformin in Preventing Diabetes in China

NCT03441750 ·Status: COMPLETED ·Phase: PHASE4

Bioequivalence Study for Acarbose/Metformin FDC

NCT04065581 ·Status: COMPLETED ·Phase: PHASE1

Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease

NCT02656017 ·Status: COMPLETED ·Phase: PHASE2